Tech Company Financing Transactions
AerovectRx Funding Round
Georgia Venture Partners and Emergent Growth Fund participated in a Series A funding round for AerovectRx. The round was announced on 9/8/2006.
Transaction Overview
Company Name
Announced On
9/8/2006
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Georgia Venture Partners (Lead Investor) (Thomas Callaway)
Proceeds Purpose
The financing enables AerovectRx to accelerate the commercialization of its proprietary inhaled drug
delivery platform technology.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
1180 Peachtree St. NE 4150
Atlanta, GA 30309
USA
Atlanta, GA 30309
USA
Phone
Website
Email Address
Overview
AerovectRx Corporation is an aerosol therapeutic company providing proprietary dosage-controlled solutions to the $12 billion inhaled drug delivery market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Kathleen Lovell
Chief Executive Officer
Thomas Callaway
Browse more venture capital transactions:
Prev: 9/7/2006: Promptu venture capital transaction
Next: 9/11/2006: Hi-G-Tek venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs